We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




European Market for EMRs to Reach $688 Million by 2010

By HospiMedica staff writers
Posted on 25 Jun 2004
The European market for electronic medical records (EMRs) is forecast to reach U.S.$688 million by 2010, with enterprise EMT systems accounting for nearly 80% of this and primary care the remainder, according to a new report from Frost & Sullivan, an international market consulting firm (London, UK). More...
Growth rates will peak in 2005 and 2006, at an average of 22.4%, due to enhanced EMR implementation in the German, French, and UK markets. These three countries are expected to account for the largest share of EMR revenues in 2010.

Misdiagnosis due to incomplete medical information and extended hospital stays caused by complications from adverse drug events (ADEs) have resulted in considerable financial losses for the European healthcare industry. As efforts are made to reduce errors and increase levels of patient safety, information technology (IT) solutions such as EMRs are emerging as enablers of high-quality, cost-effective healthcare.

Currently, the EMR industry in Europe is fragmented with several participants offering niche capabilities. This complicates efforts to achieve a consensus on industry standards for data communication and medical terminology. Diverse healthcare systems across Europe are aggravating the problem by their different payment protocols and use of clinical terminology, while instances of data not being transferable between healthcare providers, doctors, and payer organizations are likely to retard the efficacy of EMRs.
The potential of EMRs is likely to remain unrealized without continuity in data accessibility. True continuity is a critical long-term challenge and is not likely to be attained until standards are implemented for medical terminology, data exchange, and data security.

"One of the major initiatives that can make a big difference to growth in this industry is continued collaboration between vendors, providers, decision-makers, and the payers to work on developing and perfecting universally acceptable standards,” said industry analyst Siddharth Saha, of Frost & Sullivan.




Related Links:
Frost & Sullivan

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Spirometry & Oximetry Software
MIR Spiro
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.